Hunan Hansen Pharmaceutical Co., Ltd.

Shenzhen Stock Exchange 002412.SZ

Hunan Hansen Pharmaceutical Co., Ltd. Free Cash Flow for the year ending December 31, 2023: USD 19.93 M

Hunan Hansen Pharmaceutical Co., Ltd. Free Cash Flow is USD 19.93 M for the year ending December 31, 2023, a 3.93% change year over year. Free cash flow is the amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.

Hunan Hansen Pharmaceutical Co., Ltd. Free Cash Flow for the year ending December 31, 2022 was USD 19.17 M, a 825.15% change year over year.
Hunan Hansen Pharmaceutical Co., Ltd. Free Cash Flow for the year ending December 31, 2021 was USD -2.64 M, a -152.14% change year over year.
Hunan Hansen Pharmaceutical Co., Ltd. Free Cash Flow for the year ending December 31, 2020 was USD 5.07 M, a -72.71% change year over year.
Hunan Hansen Pharmaceutical Co., Ltd. Free Cash Flow for the year ending December 31, 2019 was USD 18.58 M, a -16.47% change year over year.

Key data

Date	Free Cash Flow	Operating Cash Flow	Net Cash Used For Investing Activities	Net Cash Used Provided By Financing Activities

Shenzhen Stock Exchange: 002412.SZ

Hunan Hansen Pharmaceutical Co., Ltd.

CEO	Mr. Zhengqing Liu
IPO Date	May 25, 2010
Location	China
Headquarters	No. 2688, Yincheng Avenue
Employees	1,536
Sector	Health Care
Industries Pharmaceuticals

Description

Hunan Hansen Pharmaceutical Co., Ltd. produces and sells Chinese and chemical medicine preparations in China and internationally. It provides medicines in injection, oral liquid, tablet, capsule, granule, syrup, decoction, tincture, and pill forms. The company is based in Yiyang, China.

Key trends

Past 5 years